Mackenzie Financial Corp Infinity Pharmaceuticals, Inc. Transaction History

Mackenzie Financial Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Oct 07, 2022	SELL	$0.59 - $1.7 $4,104 - $11,825	-6,956 Reduced 25.59%	20,226 $24,000
Q2 2022 Aug 10, 2022	BUY	$0.49 - $1.2 $13,319 - $32,618	27,182 New	27,182 $17,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.